Puma Biotechnology (PBYI)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 55.63 mm | 55.63 mm | 55.63 mm | 55.63 mm | 55.63 mm | 55.63 mm |
| Cash burn (monthly) | 379.00 k | 1.14 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 1.32 mm | 3.99 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 54.30 mm | 51.64 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 143.3 | 45.1 | n/a | n/a | n/a | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 112 |
| Opened positions | 25 |
| Closed positions | 18 |
| Increased positions | 48 |
| Reduced positions | 19 |
| 13F shares | Current |
|---|---|
| Total value | 82.16 bn |
| Total shares | 32.90 mm |
| Total puts | 3.40 k |
| Total calls | 27.90 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| BlackRock | 3.82 mm | $11.66 bn |
| Vanguard | 3.64 mm | $11.11 bn |
| Acorn Capital Advisors | 2.45 mm | $12.02 bn |
| Acorn Bioventures | 2.29 mm | $6.95 mm |
| Integrated Core Strategies | 2.00 mm | $7.22 mm |
| Acadian Asset Management | 1.97 mm | $6.01 mm |
| Millennium Management | 1.89 mm | $5.78 bn |
| Renaissance Technologies | 1.76 mm | $5.35 bn |
| Eversept Partners | 996.10 k | $3.04 bn |
| American Century Companies | 948.38 k | $2.89 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jan 26 | Douglas M Hunt | Common Stock | Sell | Dispose S | No | Yes | 5.879 | 5,014 | 29.48 k | 155,907 |
| 7 Jan 26 | Maximo F Nougues | Common Stock | Sell | Dispose S | No | Yes | 5.879 | 6,405 | 37.65 k | 193,284 |
| 7 Jan 26 | Auerbach Alan H | Common Stock | Sell | Dispose S | No | Yes | 5.879 | 18,012 | 105.89 k | 7,145,951 |
| 6 Jan 26 | Douglas M Hunt | Common Stock | Sell | Dispose S | No | Yes | 5.844 | 3,973 | 23.22 k | 160,921 |
| 6 Jan 26 | Maximo F Nougues | Common Stock | Sell | Dispose S | No | Yes | 5.844 | 4,540 | 26.53 k | 199,689 |
| 6 Jan 26 | Auerbach Alan H | Common Stock | Sell | Dispose S | No | Yes | 5.844 | 16,938 | 98.99 k | 7,163,963 |
| 11 Nov 25 | Miller Michael Patrick | Common Stock | Sell | Dispose S | No | No | 4.8614 | 20,000 | 97.23 k | 54,000 |
| 18 Jul 25 | Alessandra Cesano | Common Stock | Sell | Dispose S | No | Yes | 3.367 | 27,000 | 90.91 k | 41,850 |